Abstract
Although [18F]fluoro-l-dopa [FDOPA] positron emission tomography (PET) has been used as a surrogate outcome measure in Parkinson’s disease therapeutic trials, this biomarker has not been proven to reflect clinical status longitudinally. We completed a retrospective analysis of relationships between computerized sampling of motor performance, FDOPA PET, and clinical outcome scales, repeated over 4 years, in 26 Parkinson’s disease (PD) patients and 11 healthy controls. Mixed effects analyses showed that movement time and tongue strength best differentiated PD from control subjects. In the treated PD cohort, motor performance measures changed gradually in contrast to a steady decline in striatal FDOPA uptake. Prolonged reaction and movement time were related to lower caudate nucleus FDOPA uptake, and abnormalities in hand fine force control were related to mean striatal FDOPA uptake. These findings provide evidence that regional loss of nigrostriatal inputs to frontostriatal networks affects specific aspects of motor function.
Similar content being viewed by others
Abbreviations
- D:
-
Dominant side
- FDOPA:
-
[18F]fluoro-l-dopa
- MRI:
-
Magnetic resonance imaging
- ND:
-
Non-dominant side
- PD:
-
Parkinson’s disease
- PET:
-
Positron emission tomography
- UPDRS:
-
Unified Parkinson’s Disease Rating Scale
- VOI:
-
Volume of interest
References
Aarsland, D., & Kurz, M. W. (2009). The epidemiology of dementia associated with Parkinson disease. J Neurol Sci.
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357–381.
Barlow, S. M., & Abbs, J. H. (1984). Orofacial fine motor control impairments in congenital spasticity: evidence against hypertonus-related performance deficits. Neurology, 34(2), 145–150.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences, 20(4), 415–455.
Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging, 24(2), 197–211.
Brown, W. D., Taylor, M. D., Roberts, A. D., Oakes, T. R., Schueller, M. J., Holden, J. E., et al. (1999). FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology, 53(6), 1212–1218.
Bruck, A., Aalto, S., Nurmi, E., Vahlberg, T., Bergman, J., & Rinne, J. O. (2006). Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson’s disease: a two-year follow-up study. Movement Disorders, 21(7), 958–963.
Carbon, M., Felice Ghilardi, M., Dhawan, V., & Eidelberg, D. (2007). Correlates of movement initiation and velocity in Parkinson’s disease: a longitudinal PET study. Neuroimage, 34(1), 361–370.
Connor, N. P., Russell, J. A., Wang, H., Jackson, M. A., Mann, L., & Kluender, K. (2009). Effect of tongue exercise on protrusive force and muscle fiber area in aging rats. Journal of Speech, Language, and Hearing Research, 52(3), 732–744.
Crow, H. C., & Ship, J. A. (1996). Tongue strength and endurance in different aged individuals. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 51(5), M247–250.
de la Fuente-Fernandez, R., Kishore, A., Calne, D. B., Ruth, T. J., & Stoessl, A. J. (2000). Nigrostriatal dopamine system and motor lateralization. Behavioural Brain Research, 112(1–2), 63–68.
Desmurget, M., Grafton, S. T., Vindras, P., Grea, H., & Turner, R. S. (2003). Basal ganglia network mediates the control of movement amplitude. Experimental Brain Research, 153(2), 197–209.
Diederich, N. J., Moore, C. G., Leurgans, S. E., Chmura, T. A., & Goetz, C. G. (2003). Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Archives of Neurology, 60(4), 529–533.
Draper, I. T., & Johns, R. J. (1964). The disordered movement in Parkinsonism and the effect of drug treatment. Bulletin of the Johns Hopkins Hospital, 115, 465–480.
El Sharkawi, A., Ramig, L., Logemann, J. A., Pauloski, B. R., Rademaker, A. W., Smith, C. H., et al. (2002). Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. Journal of Neurology, Neurosurgery and Psychiatry, 72(1), 31–36.
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., et al. (2002). Risk tables for Parkinsonism and Parkinson’s disease. Journal of Clinical Epidemiology, 55(1), 25–31.
Evarts, E. V., Teravainen, H., & Calne, D. B. (1981). Reaction time in Parkinson’s disease. Brain, 104(Pt 1), 167–186.
Fahn, S., Elton, R. L., & Members, U. P. (1987). Unified Parkinson’s Disease Rating Scale. In S. Fahn, C. D. Marsden, M. Goldstein, & D. B. Calne (Eds.), Recent developments in Parkinsons disease (Vol. 2, p. 153–163, 293–304). Florham Park: McMillan Healthcare Information.
Flowers, K. (1975). Ballistic and corrective movements on an aiming task. Intention tremor and parkinsonian movement disorders compared. Neurology, 25(5), 413–421.
Gentil, M., Tournier, C. L., Pollak, P., & Benabid, A. L. (1999). Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson’s disease. European Neurology, 42(3), 136–140.
Gibb, W. R., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 51(6), 745–752.
Hallett, M., & Khoshbin, S. (1980). A physiological mechanism of bradykinesia. Brain, 103(2), 301–314.
Hauber, W., & Schmidt, W. J. (1994). Differential effects of lesions of the dorsomedial and dorsolateral caudate-putamen on reaction time performance in rats. Behavioural Brain Research, 60(2), 211–215.
Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: onset, progression and mortality. Neurology, 17(5), 427–442.
Lasker, A. G., & Zee, D. S. (1997). Ocular motor abnormalities in Huntington’s disease. Vision Research, 37(24), 3639–3645.
Levy, G., Louis, E. D., Cote, L., Perez, M., Mejia-Santana, H., Andrews, H., et al. (2005). Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology, 62(3), 467–472.
Marek, K., Innis, R., van Dyck, C., Fussell, B., Early, M., Eberly, S., et al. (2001). [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression. Neurology, 57(11), 2089–2094.
Montgomery, E. B., Jr., Nuessen, J., & Gorman, D. S. (1991). Reaction time and movement velocity abnormalities in Parkinson’s disease under different task conditions. Neurology, 41(9), 1476–1481.
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996a). An [18F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease. Brain, 119(Pt 2), 585–591.
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1996b). Regional changes in [18F]dopa metabolism in the striatum in Parkinson’s disease. Brain, 119(Pt 6), 2097–2103.
Nagasawa, H., Saito, H., Kogure, K., Hatazawa, J., Itoh, M., Fujiwara, T., et al. (1993). 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography. Journal of the Neurological Sciences, 115(2), 136–143.
Nocera, J., Horvat, M., & Ray, C. T. (2009). Effects of home-based exercise on postural control and sensory organization in individuals with Parkinson disease. Parkinsonism Relat Disord.
O’Day, C., Frank, E., Montgomery, A., Nichols, M., & McDade, H. (2005). Repeated tongue and hand strength measurements in normal adults and individuals with Parkinson’s disease. Intenational Journal of Orofacial Myology, 31, 15–25.
Patlak, C. S., & Blasberg, R. G. (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. Journal of Cerebral Blood Flow Metabolism, 5(4), 584–590.
Pirker, W. (2003). Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Movement Disorders, 18(Suppl 7), S43–51.
Rinne, J. O., Portin, R., Ruottinen, H., Nurmi, E., Bergman, J., Haaparanta, M., et al. (2000). Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Archives of Neurology, 57(4), 470–475.
Russmann, H., Ghika, J., Villemure, J. G., Robert, B., Bogousslavsky, J., Burkhard, P. R., et al. (2004). Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology, 63(10), 1952–1954.
Seibyl, J. P., Marek, K. L., Quinlan, D., Sheff, K., Zoghbi, S., Zea-Ponce, Y., et al. (1995). Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Annals of Neurology, 38(4), 589–598.
Solomon, N., Lorell, D., Robin, D., Rodnitzky, R., & Luscheni, E. (1995). Tongue strength and endurance in mild to moderate Parkinson’s disease. Journal of medical Speech-Language Pathology, 3, 15–26.
Stelmach, G. E., Teasdale, N., Phillips, J., & Worringham, C. J. (1989). Force production characteristics in Parkinson’s disease. Experimental Brain Research, 76(1), 165–172.
Tunik, E., Houk, J. C., & Grafton, S. T. (2009). Basal ganglia contribution to the initiation of corrective submovements. Neuroimage, 47(4), 1757–1766.
Van Dyck, C. H., Avery, R. A., MacAvoy, M. G., Marek, K. L., Quinlan, D. M., Baldwin, R. M., et al. (2008). Striatal dopamine transporters correlate with simple reaction time in elderly subjects. Neurobiology of Aging, 29, 1237–1246.
Vingerhoets, F. J., Schulzer, M., Calne, D. B., & Snow, B. J. (1997). Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Annals of Neurology, 41(1), 58–64.
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., et al. (2003). Slower progression of Parkinson’s disease with ropinirole versus levodopa: The REAL-PET study. Annals of Neurology, 54(1), 93–101.
Wing, A. M. (1988). A comparison of the rate of pinch grip force increases and decreases in Parkinsonian bradykinesia. Neuropsychologica, 26(3), 479–482.
Yousefi, B., Tadibi, V., Khoei, A. F., & Montazeri, A. (2009). Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. Trials, 10, 67.
Yust-Katz, S., Tesler, D., Treves, T. A., Melamed, E., & Djaldetti, R. (2008). Handedness as a predictor of side of onset of Parkinson’s disease. Parkinsonism & Related Disorders, 14(8), 633–635.
Acknowledgements
This work was supported with use of facilities at the William S. Middleton Memorial Veterans Hospital Geriatric Research Education and Clinical Center and the Waisman Laboratory for Brain Imaging and Behavior, Madison, WI, USA. The manuscript was edited by Gundega Korsts, Science Editor, Madison, WI.
Funding
This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Science Research and Development Service [grant to C.G]; National Institutes of Health [grant number 1R29NS31612 to D.B] and University of Wisconsin Institute for Clinical and Translational Research, funded through a National Institutes of Health Clinical and Translational Science Award, [grant number 1UL1RR025011 to C.G.].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gallagher, C.L., Johnson, S.C., Bendlin, B.B. et al. A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson’s disease. Brain Imaging and Behavior 5, 203–211 (2011). https://doi.org/10.1007/s11682-011-9124-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-011-9124-5